Indero is a specialised contract research organisation (CRO) focused on clinical research in dermatology and rheumatology. Founded in 2000, the company manages trials from early-phase translational research through to late-phase studies, with particular expertise in immune-mediated diseases. In March 2025 the firm rebranded to Indero to reflect an expanded scope of operations.
The company operates across North America, Europe, Latin America, and Asia-Pacific. Its network includes more than 3,100 investigators, and it has supported over 500 clinical trials covering more than 30 indications in dermatology and rheumatology.
Indero runs two distinct units. Innovaderm is a dedicated clinical research site, while Clinago is a patient recruitment platform. The organisation also contributes to scientific advancement through peer-reviewed publications and conducts in-house R&D initiatives.
